Mark Tripputi

772 total citations
18 papers, 431 citations indexed

About

Mark Tripputi is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Mark Tripputi has authored 18 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Mark Tripputi's work include Diabetes Management and Research (4 papers), Diabetes Treatment and Management (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Mark Tripputi is often cited by papers focused on Diabetes Management and Research (4 papers), Diabetes Treatment and Management (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Mark Tripputi collaborates with scholars based in United States and Canada. Mark Tripputi's co-authors include Simon Katz, Judith Hsia, Xue Lin, Rafael A. Irizarry, Neil A. Goldenberg, Marilyn J. Manco‐Johnson, Vera Bittner, Barbara V. Howard, Timothy J. Bernard and Vallerie V. McLaughlin and has published in prestigious journals such as New England Journal of Medicine, Circulation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mark Tripputi

18 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Tripputi United States 11 139 95 90 89 80 18 431
A. M. Carter United Kingdom 6 92 0.7× 60 0.6× 101 1.1× 54 0.6× 95 1.2× 6 362
R. A. Ajjan United Kingdom 6 102 0.7× 51 0.5× 93 1.0× 34 0.4× 38 0.5× 9 301
Søs Neergaard‐Petersen Denmark 14 54 0.4× 97 1.0× 167 1.9× 32 0.4× 51 0.6× 21 365
C. Roul France 7 133 1.0× 132 1.4× 91 1.0× 52 0.6× 92 1.1× 18 385
G Bompiani Italy 13 148 1.1× 88 0.9× 90 1.0× 47 0.5× 53 0.7× 41 433
Vanita Tongbram United States 11 61 0.4× 79 0.8× 73 0.8× 34 0.4× 78 1.0× 34 504
Predrag Miljić Serbia 15 64 0.5× 47 0.5× 95 1.1× 79 0.9× 30 0.4× 57 510
Özkan Sayan Türkiye 11 118 0.8× 44 0.5× 17 0.2× 133 1.5× 51 0.6× 31 523
G. Yazicioglu Türkiye 9 115 0.8× 40 0.4× 198 2.2× 25 0.3× 96 1.2× 12 459
Yusuke Kimishima Japan 14 55 0.4× 68 0.7× 189 2.1× 88 1.0× 35 0.4× 37 441

Countries citing papers authored by Mark Tripputi

Since Specialization
Citations

This map shows the geographic impact of Mark Tripputi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tripputi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tripputi more than expected).

Fields of papers citing papers by Mark Tripputi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tripputi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tripputi. The network helps show where Mark Tripputi may publish in the future.

Co-authorship network of co-authors of Mark Tripputi

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Tripputi. A scholar is included among the top collaborators of Mark Tripputi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Tripputi. Mark Tripputi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Molitch, Mark E., Mark Tripputi, Andrew S. Levey, et al.. (2023). Effects of metformin and intensive lifestyle interventions on the incidence of kidney disease in adults in the DPP/DPPOS. Journal of Diabetes and its Complications. 37(9). 108556–108556. 3 indexed citations
2.
Li, Josephine H., Łukasz Szczerbiński, Mark Tripputi, et al.. (2023). 1466-P: Genome-Wide Association Studies in the GRADE Study Identify Genetic Variation Influencing the Response to Pharmacotherapy for Type 2 Diabetes. Diabetes. 72(Supplement_1). 1 indexed citations
3.
Shi, Mingjian, Chuan Wang, Hao Mei, et al.. (2022). Genetic Architecture of Plasma Alpha‐Aminoadipic Acid Reveals a Relationship With High‐Density Lipoprotein Cholesterol. Journal of the American Heart Association. 11(11). e024388–e024388. 10 indexed citations
4.
Nathan, David M., John M. Lachin, Ionut Bebu, et al.. (2022). Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes. New England Journal of Medicine. 387(12). 1075–1088. 80 indexed citations
5.
Goldberg, Ronald, Mark Tripputi, Edward J. Boyko, et al.. (2021). Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study. The Journal of Clinical Endocrinology & Metabolism. 106(11). e4746–e4765. 4 indexed citations
6.
Walker, Elizabeth A., Jeffrey S. Gonzalez, Mark Tripputi, et al.. (2020). Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study. BMJ Open Diabetes Research & Care. 8(1). e001537–e001537. 13 indexed citations
7.
Utzschneider, Kristina M., Andrea Mari, Mark Tripputi, et al.. (2019). 124-OR: Comparison of OGTT Model-Derived Measures of ß-Cell Function between Youth and Adults. Diabetes. 68(Supplement_1). 1 indexed citations
8.
Craft, Suzanne, Amy Claxton, Mark Tripputi, et al.. (2019). 1561-P: Associations between ß-Cell Function and Cognitive Measures Differ in Youth vs. Adults with Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes (T2D). Diabetes. 68(Supplement_1). 1 indexed citations
9.
Beutz, Michelle, Vallerie V. McLaughlin, John Rumsfeld, et al.. (2010). Depressive Symptoms in Pulmonary Arterial Hypertension: Prevalence and Association With Functional Status. Psychosomatics. 51(4). 339–339.e8. 55 indexed citations
10.
Dreskin, Stephen C., Mark Tripputi, Michael T. Aubrey, et al.. (2010). Peanut-allergic subjects and their peanut-tolerant siblings have large differences in peanut-specific IgG that are independent of HLA class II. Clinical Immunology. 137(3). 366–373. 22 indexed citations
11.
Goldenberg, Neil A., Mark Tripputi, Mark Crowther, et al.. (2009). The “parallel-cohort RCT”: Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism. Contemporary Clinical Trials. 31(1). 131–133. 19 indexed citations
12.
Bernard, Timothy J., Neil A. Goldenberg, Mark Tripputi, et al.. (2009). Anticoagulation in Childhood-Onset Arterial Ischemic Stroke With Nonmoyamoya Arteriopathy. Stroke. 40(8). 2869–2871. 33 indexed citations
13.
Bernard, Timothy J., Laura Z. Fenton, Susan Apkon, et al.. (2009). Biomarkers of Hypercoagulability and Inflammation in Childhood-Onset Arterial Ischemic Stroke. The Journal of Pediatrics. 156(4). 651–656. 38 indexed citations
14.
Goldenberg, Neil A., et al.. (2008). Anti-Xa Stability of Diluted Dalteparin for Pediatric Use. Annals of Pharmacotherapy. 42(4). 511–515. 3 indexed citations
15.
Katz, Simon, et al.. (2006). A summarization approach for Affymetrix GeneChip data using a reference training set from a large, biologically diverse database. BMC Bioinformatics. 7(1). 464–464. 71 indexed citations
16.
Bittner, Vera, Mark Tripputi, Judith Hsia, Himanshu Gupta, & Michael W. Steffes. (2004). Remnant-like lipoproteins, hormone therapy, and angiographic and clinical outcomes: The Women's Angiographic Vitamin & Estrogen trial. American Heart Journal. 148(2). 293–299. 7 indexed citations
17.
Howard, Barbara V., Judith Hsia, Pamela Ouyang, et al.. (2004). Postmenopausal Hormone Therapy Is Associated With Atherosclerosis Progression in Women With Abnormal Glucose Tolerance. Circulation. 110(2). 201–206. 35 indexed citations
18.
Hsia, Judith, Vera Bittner, Mark Tripputi, & Barbara V. Howard. (2003). Metabolic syndrome and coronary angiographic disease progression: the Women’s Angiographic Vitamin & Estrogen trial. American Heart Journal. 146(3). 439–445. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. M. Carter Breakdown of academic impact, for papers by R. A. Ajjan Breakdown of academic impact, for papers by Søs Neergaard‐Petersen Breakdown of academic impact, for papers by C. Roul Breakdown of academic impact, for papers by G Bompiani Breakdown of academic impact, for papers by Vanita Tongbram Breakdown of academic impact, for papers by Predrag Miljić Breakdown of academic impact, for papers by Özkan Sayan Breakdown of academic impact, for papers by G. Yazicioglu Breakdown of academic impact, for papers by Yusuke Kimishima
Rankless by CCL
2026